|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM253494354 |
| 003 |
DE-627 |
| 005 |
20231224170337.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231224s2015 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1002/adma.201503869
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n0845.xml
|
| 035 |
|
|
|a (DE-627)NLM253494354
|
| 035 |
|
|
|a (NLM)26447460
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Wang, Shige
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Injectable 2D MoS2 -Integrated Drug Delivering Implant for Highly Efficient NIR-Triggered Synergistic Tumor Hyperthermia
|
| 264 |
|
1 |
|c 2015
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 20.09.2016
|
| 500 |
|
|
|a Date Revised 30.09.2020
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a © 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
|
| 520 |
|
|
|a MoS2 nanosheets and a doxorubicin (DOX)-containing poly (lactic-co-glycolic acid) (PLGA)/MoS2 /DOX composite implant are successfully constructed based on the unique phase-changing behavior of PLGA/MoS2 /DOX oleosol within tumors. The fast phase transformation can firmly restrict MoS2 and DOX within tumors, and the integrated MoS2 and DOX can endow the implant with high synergistic photothermal and chemotherapeutic efficiency against tumors
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
| 650 |
|
4 |
|a composite implants
|
| 650 |
|
4 |
|a drug delivery
|
| 650 |
|
4 |
|a molybdenum disulfides
|
| 650 |
|
4 |
|a photothermal therapies
|
| 650 |
|
4 |
|a synergistic tumor therapy
|
| 650 |
|
7 |
|a Disulfides
|2 NLM
|
| 650 |
|
7 |
|a Drug Carriers
|2 NLM
|
| 650 |
|
7 |
|a Polylactic Acid-Polyglycolic Acid Copolymer
|2 NLM
|
| 650 |
|
7 |
|a 1SIA8062RS
|2 NLM
|
| 650 |
|
7 |
|a Polyglycolic Acid
|2 NLM
|
| 650 |
|
7 |
|a 26009-03-0
|2 NLM
|
| 650 |
|
7 |
|a Lactic Acid
|2 NLM
|
| 650 |
|
7 |
|a 33X04XA5AT
|2 NLM
|
| 650 |
|
7 |
|a Doxorubicin
|2 NLM
|
| 650 |
|
7 |
|a 80168379AG
|2 NLM
|
| 650 |
|
7 |
|a Molybdenum
|2 NLM
|
| 650 |
|
7 |
|a 81AH48963U
|2 NLM
|
| 650 |
|
7 |
|a molybdenum disulfide
|2 NLM
|
| 650 |
|
7 |
|a ZC8B4P503V
|2 NLM
|
| 700 |
1 |
|
|a Chen, Yu
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Li, Xiang
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Gao, Wei
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zhang, Linlin
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Liu, Jun
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zheng, Yuanyi
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Chen, Hangrong
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Shi, Jianlin
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 27(2015), 44 vom: 25. Nov., Seite 7117-22
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
| 773 |
1 |
8 |
|g volume:27
|g year:2015
|g number:44
|g day:25
|g month:11
|g pages:7117-22
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.201503869
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 27
|j 2015
|e 44
|b 25
|c 11
|h 7117-22
|